Cargando…

Is there any kind of relationship between alpha-1 antitrypsin levels and lung function parameters?

Detalles Bibliográficos
Autores principales:	Hernández-Pérez, José María, López-Charry, Claudia Viviana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970365/ https://www.ncbi.nlm.nih.gov/pubmed/36790284 http://dx.doi.org/10.36416/1806-3756/e20220432

Ejemplares similares

Is the determination of C‐reactive protein really necessary in the diagnosis of Alpha‐1 antitrypsin deficiency?
por: Hernández‐Pérez, José María, et al.
Publicado: (2022)

Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency
por: María Hernández Pérez, José, et al.
Publicado: (2022)

Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection
por: Hernández Pérez, José María, et al.
Publicado: (2021)

Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency
por: McCarthy, Cormac, et al.
Publicado: (2021)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

Description of 22 new alpha-1 antitrypsin genetic variants
por: Renoux, Céline, et al.
Publicado: (2018)

How are we in Brazil with the treatment of alpha-1 antitrypsin deficiency?
por: Castellano, Maria Vera Cruz de Oliveira, et al.
Publicado: (2022)

The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013)

Respuesta al artículo prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores
por: Hernández Pérez, José María, et al.
Publicado: (2019)

Detección de casos de déficit de alfa-1 antitripsina, ¿restringimos o ampliamos?
por: Hernández Pérez, José María, et al.
Publicado: (2023)

¿Puede ser la deficiencia de alfa-1 antitripsina un factor protector contra la hipertensión arterial y la cardiopatía isquémica?
por: Hernández Pérez, José María, et al.
Publicado: (2022)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

COVID-19 and Hydatidosis Infections: Is There Any Relationship?
por: Matin, Somayeh, et al.
Publicado: (2021)

Klinefelter syndrome and bronchial asthma: Is there any relationship between the low testosterone levels and asthma exacerbations?
por: Ladias, Spyros, et al.
Publicado: (2018)

Methodologies for the Determination of Blood Alpha1 Antitrypsin Levels: A Systematic Review
por: Ruiz-Duque, Borja, et al.
Publicado: (2021)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Optimal alpha-1 antitrypsin level cutoffs for genotype identification in patients with chronic liver disease
por: Prakash, Sameer, et al.
Publicado: (2023)

COVID-19 incidence and local ozone level: is there any association?
por: Joob, Beuy, et al.
Publicado: (2021)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
por: Evans, H E, et al.
Publicado: (1979)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
por: Torres-Durán, María, et al.
Publicado: (2023)

Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
por: Bianchera, Annalisa, et al.
Publicado: (2023)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Active Trafficking of Alpha 1 Antitrypsin across the Lung Endothelium
por: Lockett, Angelia D., et al.
Publicado: (2014)

Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency
por: Zamora, Martin R., et al.
Publicado: (2021)

Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review
por: Tubío-Pérez, Ramón A., et al.
Publicado: (2020)

Determination of Alpha-1 Antitrypsin Level in Patients with Severe Asthma
por: Mousavi, Seyed Ali-Javad, et al.
Publicado: (2013)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Pilomatrixoma arising from maxillary sinus – First of its kind
por: Sruthi, T. R., et al.
Publicado: (2019)

Is There Any Relationship Between Coverage and Achieve Rates of Influenza Vaccination?: A Report from an Endemic Country
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function
por: Kokturk, Nurdan, et al.
Publicado: (2023)

Is There Any Help?
Publicado: (1888)

Do fragment multiplicity distributions obey any kind of scaling?
por: Waged, K E, et al.
Publicado: (1994)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Furazolidone and Serotonin Syndrome: Is there any Association?
por: Karamanakos, Petros N
Publicado: (2008)

Permissive hypercapnia: Is there any upper limit?
por: Nayak, Snehamayee, et al.
Publicado: (2015)

Both kinds of RNase P in all domains of life: surprises galore
por: Daniels, Charles J., et al.
Publicado: (2019)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
por: Calle Rubio, Myriam, et al.
Publicado: (2023)

Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice
por: Ostermann, Lena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rjb1d4382imefqh5flf0d4ja4